Literature DB >> 25501800

Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy--pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry.

Shinya Suzuki1, Takeshi Yamashita, Ken Okumura, Hirotsugu Atarashi, Masaharu Akao, Hisashi Ogawa, Hiroshi Inoue.   

Abstract

BACKGROUND: The incidence rate of ischemic stroke in Japanese non-valvular atrial fibrillation (NVAF) patients without anticoagulation therapy remains unclear. METHODS AND
RESULTS: We performed a pooled analysis of 3,588 patients from the Shinken Database (n=1,099), J-RHYTHM Registry (n=1,002), and Fushimi AF Registry (n=1,487) to determine the incidence rate of ischemic stroke in Japanese NVAF patients without anticoagulation therapy. Average patient age was 68.1 years. During the follow-up period (total, 5,188 person-years; average, 1.4 years), 69 patients suffered from ischemic stroke (13.3 per 1,000 person-years; 95% confidence intervals [CI]: 10.5-16.8). The incidence rates of ischemic stroke were 5.4, 9.3, and 24.7 per 1,000 person-years and 5.3, 5.5, and 18.4 per 1,000 person-years in patients with low (0), intermediate (1), and high (≥ 2) CHADS2 and CHA2DS2-VASc scores, respectively. History of ischemic stroke or transient ischemic attack (hazard ratio [HR], 3.25; 95% CI: 1.86-5.67), age ≥ 75 years (HR, 2.31; 95% CI: 1.18-4.52), and hypertension (HR, 1.69; 95% CI: 1.01-2.86) were independent risk factors for ischemic stroke.
CONCLUSIONS: A low incidence rate of ischemic stroke was observed in Japanese NVAF patients except for those with CHADS2 score ≥ 2. In this pooled analysis, history of ischemic stroke or transient ischemic attack, advanced age, and hypertension were identified as independent risk factors for ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25501800     DOI: 10.1253/circj.CJ-14-1131

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  27 in total

1.  Stroke prevention in atrial fibrillation: the Singapore story.

Authors:  Pow-Li Chia
Journal:  Singapore Med J       Date:  2020-12       Impact factor: 1.858

2.  The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores.

Authors:  Takumi Kondo; Takahisa Yamada; Takashi Morita; Yoshio Furukawa; Shunsuke Tamaki; Yusuke Iwasaki; Masato Kawasaki; Atsushi Kikuchi; Tsutomu Kawai; Satoshi Takahashi; Masashi Ishimi; Hideyuki Hakui; Tatsuhisa Ozaki; Yoshihiro Sato; Masahiro Seo; Yasushi Sakata; Masatake Fukunami
Journal:  Heart Vessels       Date:  2016-06-21       Impact factor: 2.037

3.  Assessment of atrial fibrillation ablation outcomes with clinic ECG, monthly 24-h Holter ECG, and twice-daily telemonitoring ECG.

Authors:  Takehiro Kimura; Yoshiyasu Aizawa; Naomi Kurata; Kazuaki Nakajima; Shin Kashimura; Akira Kunitomi; Takahiko Nishiyama; Yoshinori Katsumata; Nobuhiro Nishiyama; Kotaro Fukumoto; Yoko Tanimoto; Keiichi Fukuda; Seiji Takatsuki
Journal:  Heart Vessels       Date:  2016-07-06       Impact factor: 2.037

4.  Screening for untreated atrial fibrillation in the elderly population: A community-based study.

Authors:  Keitaro Senoo; Arito Yukawa; Takashi Ohkura; Keisuke Shoji; Masao Takigami; Hibiki Iwakoshi; Tetsuro Nishimura; Mitsuko Nakata; Satoshi Teramukai; Satoaki Matoba
Journal:  PLoS One       Date:  2022-06-06       Impact factor: 3.752

5.  The Characteristics and Clinical Outcomes of Direct Oral Anticoagulantsin Patients with Atrial Fibrillation and Chronic Kidney Disease: From the Database of A Single-Center Registry.

Authors:  Takao Sato; Yoshifusa Aizawa; Hitoshi Kitazawa; Masaaki Okabe
Journal:  J Atr Fibrillation       Date:  2020-08-31

6.  Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.

Authors:  Mi Kyoung Son; Nam-Kyoo Lim; Hyung Woo Kim; Hyun-Young Park
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

Review 7.  Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.

Authors:  Tatjana S Potpara; Nikolaos Dagres; Nebojša Mujović; Dragan Vasić; Milika Ašanin; Milan Nedeljkovic; Francisco Marin; Laurent Fauchier; Carina Blomstrom-Lundqvist; Gregory Y H Lip
Journal:  Adv Ther       Date:  2016-12-08       Impact factor: 3.845

8.  Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J-RHYTHM Registry.

Authors:  Eitaro Kodani; Hirotsugu Atarashi; Hiroshi Inoue; Ken Okumura; Takeshi Yamashita; Toshiaki Otsuka; Hirofumi Tomita; Hideki Origasa
Journal:  J Am Heart Assoc       Date:  2016-09-12       Impact factor: 5.501

9.  2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.

Authors:  Chern-En Chiang; Ken Okumura; Shu Zhang; Tze-Fan Chao; Chung-Wah Siu; Toon Wei Lim; Anil Saxena; Yoshihide Takahashi; Wee Siong Teo
Journal:  J Arrhythm       Date:  2017-06-27

10.  Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry.

Authors:  Yasuo Okumura; Katsuaki Yokoyama; Naoya Matsumoto; Eizo Tachibana; Keiichiro Kuronuma; Koji Oiwa; Michiaki Matsumoto; Toshiaki Kojima; Shoji Hanada; Kazumiki Nomoto; Ken Arima; Fumiyuki Takahashi; Tomobumi Kotani; Yukitoshi Ikeya; Seiji Fukushima; Satoru Itoh; Kunio Kondo; Masaaki Chiku; Yasumi Ohno; Motoyuki Onikura; Atsushi Hirayama
Journal:  J Arrhythm       Date:  2017-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.